Literature DB >> 20430456

Increasing marginal utility of small increases in life-expectancy? Results from a population survey.

Maria Knoph Kvamme1, Dorte Gyrd-Hansen, Jan Abel Olsen, Ivar Sønbø Kristiansen.   

Abstract

The standard practice in cost-effectiveness analyses of health care is to assign a linear value to increasing lifetime gains. The aim of the current study was to examine the possible existence of non-linear utility for short life extensions. A representative sample of the Norwegian population, aged 40-59 years (n=2402), was asked to imagine that they had a limited remaining lifetime (1 year or 10 years) and were offered a treatment that would increase lifetime by a specified amount of time from 1 week to 1 year. In all scenarios, the price per week of life extension was held constant. The proportion of respondents that accepted the treatment increased with increasing extensions, indicating a convex utility function. The result suggests increasing marginal utility for life extensions up to 1 year.

Mesh:

Year:  2010        PMID: 20430456     DOI: 10.1016/j.jhealeco.2010.03.010

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  4 in total

1.  Unravelling drug reimbursement outcomes: a comparative study of the role of pharmacoeconomic evidence in Dutch and Swedish reimbursement decision making.

Authors:  Margreet Franken; Fredrik Nilsson; Frank Sandmann; Anthonius de Boer; Marc Koopmanschap
Journal:  Pharmacoeconomics       Date:  2013-09       Impact factor: 4.981

2.  Lifetime QALY prioritarianism in priority setting: quantification of the inherent trade-off.

Authors:  Trygve Ottersen; Ottar Mæstad; Ole Frithjof Norheim
Journal:  Cost Eff Resour Alloc       Date:  2014-01-14

3.  Estimating a constant WTP for a QALY-a mission impossible?

Authors:  Björn Sund; Mikael Svensson
Journal:  Eur J Health Econ       Date:  2017-09-21

Review 4.  Estimating QALY gains in applied studies: a review of cost-utility analyses published in 2010.

Authors:  Torbjørn Wisløff; Gunhild Hagen; Vida Hamidi; Espen Movik; Marianne Klemp; Jan Abel Olsen
Journal:  Pharmacoeconomics       Date:  2014-04       Impact factor: 4.981

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.